Aurora Cannabis Invests in German Facility to Enhance European Operations and Product Quality

Aurora Cannabis Strengthens European Operations with Major Investment in Germany

Aurora Cannabis Inc. announces a pivotal investment over the next five years aimed at enhancing its EU-GMP manufacturing facility located in Leuna, Germany. This strategic initiative is set to adopt advanced global manufacturing practices, which will significantly boost the facility's flower growth capacity, product quality, and overall cost efficiency. Alex Miller, the Executive Vice President of Operations at Aurora, underscores the importance of these upgrades, noting they are essential for achieving operational excellence and fostering long-term growth in the European market. As demand for high-quality medical cannabis continues to rise, Aurora positions itself to meet this need effectively.

The enhancements to the Leuna facility include the addition of new grow rooms, state-of-the-art irrigation and lighting systems, and the implementation of advanced drying techniques. These upgrades are particularly vital as Aurora Leuna stands as one of only three licensed cultivation facilities in Germany. This strategic location allows Aurora to supply locally grown medical cannabis to a growing patient base, operating under the IndiMed brand. Furthermore, the company plans to diversify its offerings by introducing more cultivars from its extensive genetics library, thereby enhancing its product lineup and catering to a broader spectrum of patient needs.

Aurora's commitment to its operational capabilities is evident in this investment, reflecting its dedication to maintaining high standards in serving international markets. With a global footprint that spans Canada, Europe, Australia, and New Zealand, Aurora is well-positioned to capitalize on the expanding cannabis market. The company offers a diverse range of products, including medical brands like MedReleaf and CanniMed, and consumer brands such as Drift and San Rafael '71. This strategic investment not only strengthens Aurora's position in Europe but also reinforces its reputation as an industry leader focused on innovation, quality, and scientific excellence.

In addition to its European operations, Aurora Cannabis maintains a strong presence in the global cannabis landscape. The company also holds a controlling interest in Bevo Farms Ltd., a key supplier of propagated agricultural plants, further enhancing its operational versatility. With an unwavering focus on quality and innovation, Aurora continues to pave the way in the medical, wellness, and recreational cannabis markets, ensuring its readiness to adapt and thrive in an evolving industry.